Skip to Content

APO 047 250 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint APO 047 250 is White, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Apotex Corp..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 047 250

Divalproex sodium delayed-release 250 mg APO 047 250

Divalproex Sodium Delayed-Release

Imprint:
APO 047 250
Strength:
250 mg
Color:
White
Size:
15.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
National Drug Code (NDC):
60505-3066

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide